Norris Medicines has informed that a meeting of Board of Directors of the Company will be held on Wednesday, the 23rd October, 2019, to consider and approve Unaudited Financial Results of the Company for the Quarter ended 30th September, 2019.
The above information is a part of company’s filings submitted to BSE.